Co-occurrence of tobacco product use, substance use, and mental health problems among youth: Findings from wave 1 (2013–2014) of the population assessment of tobacco and health (PATH) study

Conway, Kevin P.; Green, Victoria R.; Kasza, Karin A.; Silveira, Marushka L.; Borek, Nicolette; Kimmel, Heather L.; Sargent, James D.; Stanton, Cassandra A.; Lambert, Elizabeth; Hilmi, Nahla; Reissig, Chad J.; Jackson, Kia J.; Tanski, Susanne E.; Maklan, David; Hyland, Andrew; Compton, Wilson M.

doi:10.1016/j.addbeh.2017.08.009

Cited by 98 publications

(85 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…", was omitted. Response options for each item were summed to create a mean score (10). The scale is internally consistent among youth in the PATH Study (Cronbach's α=0.76).…”

Section: Methodsmentioning

confidence: 99%

“…Internalizing and externalizing problems were assessed via modified subscales of the Global Appraisal of Individual Needs -Short Screener (GAIN-SS) (29) and categorized into no/low/moderate (0-3 symptoms) or high (4/4+ symptoms) severity (10). The response option "1+ years ago" for both subscales was modified to "Over a year ago".…”

Section: Methodsmentioning

confidence: 99%

“…Among youth who use tobacco, multiple product use is common (7,8), especially among high school students (5). Moreover, youth tobacco users, particularly those who use multiple tobacco products, are also more likely to use alcohol and drugs and to report substance use disorders (SUDs) (8)(9)(10)(11). These youth are at risk for several immediate adverse outcomes including dropping out of high school and lower educational attainment (12), cognitive impairment (13), and problem behaviors (e.g.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Patterns and correlates of polysubstance use among US youth aged 15–17 years: wave 1 of the Population Assessment of Tobacco and Health (PATH) Study

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…", was omitted. Response options for each item were summed to create a mean score (10). The scale is internally consistent among youth in the PATH Study (Cronbach's α=0.76).…”

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Patterns and correlates of polysubstance use among US youth aged 15–17 years: wave 1 of the Population Assessment of Tobacco and Health (PATH) Study

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…Mental health problems were assessed via the Global Appraisal of Individual NeedsÀShort Screener (GAIN-SS), modified for the PATH Study. 20,21 The GAIN-SS is a 3-to 5-minute screener that identifies individuals at risk for mental health or substance use disorders using a continuous measure of severity, based on the number of items endorsed. Items for the GAIN-SS were derived from the full GAIN instrument, a validated, standardized biopsychosocial assessment for individuals entering treatment for substance use or mental health disorders 22 and recommended for use in epidemiological samples by the PhenX Toolkit.…”

Section: Methodsmentioning

confidence: 99%

“…Based on the number of symptoms endorsed for each of the 2 subscales, respectively, participants were categorized into no/ low/moderate (0À3 symptoms) or high (4 symptoms for internalizing problems or !4 symptoms for externalizing problems) severity levels. These cutpoints were determined based on previous analyses, 20,21 with the goal of examining those participants deemed to be at highest risk for a mental health problem (ie, high-severity). Although the GAIN-SS is not a diagnostic tool, no/low severity indicates a low likelihood of diagnosis with need for services, moderate-severity indicates a potential diagnosis with need for services, and high-severity indicates a high likelihood of a diagnosis with need for services.…”

Section: Methodsmentioning

confidence: 99%

Mental Health Problems and Onset of Tobacco Use Among 12- to 24-Year-Olds in the PATH Study

Green

Conway

Silveira

et al. 2018

Journal of the American Academy of Child & Adolescent Psych

Self Cite

View full text Add to dashboard Cite

Objective: To examine whether mental health problems predict incident use of 12 different tobacco products in a nationally representative sample of youth and young adults. Method: This study analyzed Wave (W) 1 and W2 data from 10,533 12-to 24-year-old W1 never tobacco users in the Population Assessment of Tobacco and Health (PATH) Study. Self-reported lifetime internalizing and externalizing symptoms were assessed at W1. Past 12-month use of cigarettes, electronic nicotine delivery systems (ENDS), traditional cigars, cigarillos, filtered cigars, pipe, hookah, snus pouches, other smokeless tobacco, bidis and kreteks (youth only), and dissolvable tobacco was assessed at W2. Results: In multivariable regression analyses, high-severity W1 internalizing (adjusted odds ratio [AOR] ¼ 1.5, 95% CI ¼ 1.3À1.8) and externalizing (AOR ¼ 1.3, 95% CI ¼ 1.1À1.5) problems predicted W2 onset of any tobacco use compared to no/low/moderate severity. High-severity W1 internalizing problems predicted W2 use onset across most tobacco products. High-severity W1 externalizing problems predicted onset of any tobacco (AOR ¼ 1.6, 95% CI ¼ 1.3À1.8), cigarettes (AOR ¼ 1.4, 95% CI ¼ 1.0À2.0), ENDS (AOR ¼ 1.8, 95% CI ¼ 1.5À2.1), and cigarillos (AOR ¼ 1.5, 95% CI ¼ 1.0À2.1) among youth only. Conclusion: Internalizing and externalizing problems predicted onset of any tobacco use. However, findings differed for internalizing and externalizing problems across tobacco products, and by age, gender, and race/ethnicity. In addition to screening for tobacco product use, health care providers should screen for a range of mental health problems as a predictor of tobacco use. Interventions addressing mental health problems may prevent youth from initiating tobacco use.

show abstract

Association of Electronic Nicotine Delivery System Use With Cigarette Smoking Relapse Among Former Smokers in the United States

et al. 2020

Self Cite

View full text Add to dashboard Cite

IMPORTANCE Relapse to smoking among former smokers is a serious clinical concern, and use of electronic nicotine delivery systems (ENDS) has been proposed as a new risk factor for relapse. Understanding the specificity of this risk can help guide clinical practice and lead to improved health outcomes. OBJECTIVE To assess the associations of ENDS use with cigarette smoking relapse among adult former cigarette smokers. DESIGN, SETTING, AND PARTICIPANTS This cohort study examined data from the Population Assessment of Tobacco and Health Study, waves 1 to 4 (2013-2018). Cox proportional hazards models were developed. This is an ongoing, nationally representative, longitudinal cohort study in the US. Participants included adult (Ն18 years) former cigarette smokers who reported no tobacco product use at wave 1 (unweighted n = 2273), separated into recent former cigarette smokers (last smoked Յ12 months previously) and long-term former smokers (last smoked >12 months previously). Data analysis was conducted from July to August 2019. EXPOSURES Self-reported use of cigarettes, ENDS, and other tobacco products (ie, cigars, pipe tobacco, hookah, snus tobacco, other smokeless tobacco, and dissolvable tobacco) was assessed. MAIN OUTCOMES AND MEASURES Self-reported current (every day or some days) use of cigarettes at follow-up interviews. RESULTS Of 2273 adult former cigarette smokers, 51.8% (95% CI, 49.7%-53.8%) were women, 65.0% (95% CI, 62.6%-67.4%) were older than 50 years, and 79.5% (95% CI, 77.8%-81.2%) were non-Hispanic white participants. Use of ENDS was associated with significant risk of cigarette smoking relapse among recent former smokers (adjusted hazard ratio [AHR], 1.63; 95% CI, 1.04-2.53; unweighted n = 304) and among long-term former smokers (AHR, 3.79; 95% CI, 1.75-8.20; unweighted n = 1554). Use of other tobacco products was also associated with significant risk for cigarette smoking relapse among recent former smokers (AHR, 1.97; 95% CI, 1.27-3.05) and among long-term former smokers (AHR, 3.82; 95% CI, 1.91-7.66). CONCLUSIONS AND RELEVANCE In this study, use of ENDS and other tobacco products was associated with increased risk of cigarette smoking relapse among former cigarette smokers who did not use any tobacco product at wave 1 of the PATH Study. For clinicians treating former smokers who have successfully quit all nicotine products, the implications are that use of ENDS products should be discouraged, just as use of all other tobacco products is discouraged.

show abstract

Co-occurrence of tobacco product use, substance use, and mental health problems among youth: Findings from wave 1 (2013–2014) of the population assessment of tobacco and health (PATH) study

Cited by 98 publications

References 41 publications

Patterns and correlates of polysubstance use among US youth aged 15–17 years: wave 1 of the Population Assessment of Tobacco and Health (PATH) Study

Patterns and correlates of polysubstance use among US youth aged 15–17 years: wave 1 of the Population Assessment of Tobacco and Health (PATH) Study

Mental Health Problems and Onset of Tobacco Use Among 12- to 24-Year-Olds in the PATH Study

Association of Electronic Nicotine Delivery System Use With Cigarette Smoking Relapse Among Former Smokers in the United States

Contact Info

Product

Resources

About